Summary
This 8-K/A filing from Cigna Group (CI) serves as an amendment to a previous report filed on October 29, 2019. The primary purpose of this amendment is to provide additional details regarding the appointment of Kimberly A. Ross as an independent member of the Board of Directors. While her appointment was initially announced, this filing clarifies her committee assignments and qualifications. Specifically, Ms. Ross has been appointed to the Audit Committee and the Finance Committee, effective June 1, 2020. Furthermore, the Board has determined that she is financially literate and designated her as an audit committee financial expert, meeting SEC requirements. This information is crucial for investors to understand the composition and expertise of the Board, particularly within key oversight committees.
Key Highlights
- 1Amendment to a prior 8-K filing regarding board changes.
- 2Kimberly A. Ross's appointment as an independent director is confirmed.
- 3Ms. Ross's committee assignments are now specified: Audit Committee and Finance Committee.
- 4Ms. Ross's appointment to these committees is effective June 1, 2020.
- 5The Board has determined Ms. Ross is financially literate.
- 6Ms. Ross has been designated as an audit committee financial expert.
- 7This filing provides clarity on the qualifications and roles of a new board member.